Takeda releases internal probe over bad ad

Share this article:

Japanese drugmaker Takeda has released the results of an internal probe over an inappropriate ad for blood pressure medicine BIopress, which, according to the Wall Street Journal, utilized an incorrect chart and “raised suggestions of manipulated trial data.” The company denies wrongdoing. The report is only available in Japanese, however, and WSJ reports that questions regarding an English version have gone unanswered, raising questions on whether the company is trying to be transparent, or merely to appear transparent.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions